Insider · CIK 0001213867
John L Erb
Files at NUWE (Nuwellis, Inc.), MIRO (Miromatrix Medical Inc.). First filing -, latest -.
In brief
John L Erb files SEC Form 4 as CEO, president, director and 10% owner at NUWE (Nuwellis, Inc.), and also at MIRO (Miromatrix Medical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John L Erb has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | NUWE Nuwellis, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +115,329 | $0.00 | $0 | 115,329 | Jul 1, 2025 |
| Jun 9, 2025 | NUWE Nuwellis, Inc. | CConversion Common Stock | +1,092,500 | $0.06 | $66k | 1,092,500 | Jun 11, 2025 |
| Jun 10, 2025 | NUWE Nuwellis, Inc. | CConversion Common Stock | +7,522 | $0.06 | $451 | 1,100,022 | Jun 11, 2025 |
| Jun 9, 2025 | NUWE Nuwellis, Inc. | JOther Series F Convertible Preferred Stockderivative | -100 | - | - | 0 | Jun 11, 2025 |
| Jun 9, 2025 | NUWE Nuwellis, Inc. | JOther Series F-1 Convertible Preferred Stockderivative | +100 | - | - | 100 | Jun 11, 2025 |
| Jun 9, 2025 | NUWE Nuwellis, Inc. | CConversion Series F-1 Convertible Preferred Stockderivative | -66 | - | - | 34 | Jun 11, 2025 |
| Dec 12, 2023 | MIRO Miromatrix Medical Inc. | UTender of shares Common Stock | -56,260 | - | - | 54,201 | Dec 13, 2023 |
| Dec 13, 2023 | MIRO Miromatrix Medical Inc. | DDisposition to issuer Common Stock | -54,201 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | MIRO Miromatrix Medical Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | MIRO Miromatrix Medical Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,750 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | MIRO Miromatrix Medical Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | MIRO Miromatrix Medical Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | MIRO Miromatrix Medical Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
Questions about John L Erb
Answered from the filings on this page, as of the latest one.
Is John L Erb buying or selling?
John L Erb has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John L Erb's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John L Erb has 0.
Where does John L Erb file Form 4?
John L Erb has filed Form 4 at NUWE (Nuwellis, Inc.) as CEO and President; MIRO (Miromatrix Medical Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.